The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia. [PDF]
Candan O +10 more
europepmc +1 more source
Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques [PDF]
Diamond, Michael S +3 more
core +1 more source
Does dosing frequency of anti‐CD20 therapies blunt vaccine responses and increase COVID‐19 susceptibility in patients with multiple sclerosis? [PDF]
Jagannadha Avasarala
openalex +1 more source
Summary Lymphoma in horses is uncommon and rarely diagnosed as a cause of ataxia. This case report describes a 2‐year‐old Standardbred cryptorchid colt who presented with acute onset of grade 3–4/5 spinal ataxia in all four limbs, with the hindlimbs more severely affected than forelimbs and severe proprioceptive deficits.
K. MacMillan +3 more
wiley +1 more source
Obinutuzumab in kidney transplantation: Past, present, and future. [PDF]
Favi E, Morabito M.
europepmc +1 more source
Summary An 18‐year‐old Warmblood mare was presented to the Royal Veterinary College Equine Referral Hospital for investigation of progressive periocular and facial swelling, weight loss and tachycardia. Physical examination additionally identified bilateral pansystolic (grade 5/6 basilar left‐sided, 2/6 right‐sided), cardiac murmurs, submandibular ...
S. E. Talbot +4 more
wiley +1 more source
Real-World Perspectives on Switching Patients with Multiple Sclerosis from Anti-CD20 Therapy to Cladribine Tablets from USA-Based Advanced Practice Providers: A Podcast. [PDF]
Kutz CF, Roman C.
europepmc +1 more source
10 Innovative preclinical mouse models support the development of CD3/CD20 bispecific antibodies [PDF]
Linlin Wang, Chong Li, Xiaofei Zhou
openalex +1 more source

